Form 4 for CI Cigna
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001225208-25-002928 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-04 | 2025-02-28 | CI | Kates Jamie G | CAO | A - Grant | $0.00 | +651 | 1,867 | +54% | $0 |
| DM | 2025-03-04 | 2025-02-28 | CI | Kates Jamie G | CAO | F - Tax | $305.86 | -181 | 1,816 | -9% | -$55.4K |
| D | 2025-03-04 | 2025-02-28 | CI | Kates Jamie G | CAO | A - Grant | $0.00 | +871 | 871 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2025-02-28 | A | A | 405 | $0.00 | 1,621 | D | — | — | (F1) The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| 2 | Common | Common Stock, $.01 Par Value | 2025-02-28 | A | A | 246 | $0.00 | 1,867 | D | — | — | (F2) These restricted shares vest in three equal annual installments beginning March 1, 2026. |
| 3 | Common | Common Stock, $.01 Par Value | 2025-02-28 | F | D | 130 | $305.86 | 1,686 | D | — | — | (F4) Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| 4 | Common | Common Stock, $.01 Par Value | 2025-02-28 | F | D | 51 | $305.86 | 1,816 | D | — | — | (F3) Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2025-02-28 | A | A | 871 | $0.00 | 871 | D | $305.86 · 2026-03-01 to 2035-02-28 | 871 Common Stock, $.01 Par Value | (F5) This option vests in three equal annual installments beginning March 1, 2026. |